Debrillator-Monitor Cleared by FDA for Home Use

An automatic defibrillator-monitor that can deliver a defibrillation shock within seconds to restore normal heart rhythm has been cleared by the U.S. Food and Drug Administration (FDA) for out-of-hospital applications, including at-home use.

Called Powerheart, the defibrillator-monitor is the product of Cardiac Science Inc. (Irvine, CA, USA). The new indication will allow doctors to attach Powerheart to patients undergoing outpatient or office-based surgical procedures who are deemed at risk for developing cardiac arrhythmias.

In addition, Cardiac Science sees enormous potential for Powerheart to be prescribed for use at home on patients who are at temporary risk of developing life-threatening rhythms while recovering from cardiac surgery, angioplasty, adjustment of anti-arrhythmic medications, or treatment for congestive heart failure. Powerheart instantly detects the onset of an abnormal heart rhythm and automatically delivers defibrillation without intervention.



Related Links:
Cardiac Science